About the NIH Clinical Center

NIH Clinical Trials Search Page

Return to NIH Listings Menu

Non-NIH Trial Listings

Research centers specializing in this illness area

Additional resources in this illness area

NIH Studies: Ophthalmology

Below is a listing of government-funded clinical trials in Ophthalmology, being conducted by the various National Institutes of Health at the Warren Grant Magnuson Clinical Center in Bethesda, MD.

Click on a study summary to view the study description and contact information directly from the NIH's web site.

[*]Pilot Study of Intravitreal Injection of Ranibizumab (rhuFAB V2) for Advanced Ocular Disease of Von Hippel-Lindau Disease

[*]Screening Study for the Evaluation and Diagnosis of Potential Research Subjects with Anterior Segment Disease

[*]Clinical and Molecular Studies in Families with Myopia and Related Diseases

[*]Phase II Study of Implants of Encapsulated Human NTC-201 Cells Releasing Ciliary Neurotrophic Factor (CNTF), in Participants with Visual Acuity Impairment Associated with Atrophic Macular Degeneration

[*]National Ophthalmic Genotyping Network Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases

[*]Clinical and Molecular Studies in Families with Glaucoma and Related Diseases

[*]Evaluation and Treatment Protocol for Patients with Retinal Disease

[*]Multicenter Uveitis Steroid Treatment (MUST) Trial Protocol

[*]Use of Immune Cell Markers, Cytokines, and Transcription Factors as Markers of Intraocular Inflammatory Activity

[*]Phenotype-Genotype Correlation in Aniridia

[*]Screening Study for the Evaluation and Diagnosis of Potential Research Subjects with Ocular Inflammatory or Immunologic Diseases

[*]Evaluation and Treatment Protocol of Patients with Corneal and External Diseases

[*]Evaluation and Treatment Protocol for Potential Research Subjects with Inherited Ophthalmic Diseases

[*]Screening Study for the Evaluation and Diagnosis of Potential Research Subjects with Nystagmus or Strabismus

[*]Screening Study for the Evaluation and Diagnosis of Potential Research Subjects with Retinovascular Diseases

[*]Screening Study for the Evaluation and Diagnosis of Potential Research Subjects with Inherited Ophthalmic Diseases

[*]A Study of Crystalline Proteins in Young Normal Lenses Using the NASA-NEI Dynamic Light Scattering (DLS) Device

[*]The Vitreous Proteome and inflammatory Mediators in Ocular Inflammatory Disease

[*]Evaluation and Treatment Protocol for Patients with Intraocular Inflammatory Disease (Uveitis)

[*]Age-Related Eye Disease Study - Phase II

[*]Trial of Treatment of Non-Infectious Intermediate and Posterior Uveitis with Humanized Anti-Tac Antibody Therapy

[*]Visual Motor Coordination in Man

[*]Trial of Topical Cysteamine in the Treatment of Corneal Cystine Crystal Accumulation in Cystinosis

[*]Treatment of Choroidal Subretinal Neovascularization with Agents Directed Against the Immune Response

[*]Pathogenesis of Focal Segmental Glomerulosclerosis

[*]A Phase II Study of OT-551 Antioxidant Eye Drop in Participation with Bilateral Geographic Atrophy Associated with Age-Related Macular Degeneration

[*]Immunopathology of Ocular Disease in Humans

[*]Top-Down Attentional Control of Visual Processing

[*]Familial Exudative Vitreoretinopathy Clinical and Molecular Studies

[*]Digital Image Based Determination of Ocular Surface Vital Dye Staining

[*]Daclizumab for Active, Non-infectious, Sight-threatening Uveitis: A Phase II Pilot Study

[*]Phase I Study of Intravitreal Injections Versus Anterior Sub-Tenon Injections of Triamcinolone Acetonide Formulation for Macular Edema in Retinal Disorders

[*]Identification of Biological Markers in Retinal Vasculitis

[*]Combination Daclizumab/Sirolimus Therapy For the Induction of Immune Tolerance in Non-Infectious Intermediate and Posterior Uveitis

[*]Pilot Study of Intravitreal Injection of Triamcinolone Acetonide Formulation for Retinal Vascular Disorders

[*]Treatment of Non-Infectious Intermediate and Posterior Uveitis Associated Macular Edema with Humanized Anti-CD11a Antibody Therapy

[*]A Pilot Study of Laser Photocoagulation for Diabetic Macular Edema

[*]Systemic Immunosupressive Therapy for Eye Diseases (SITE) Cohort Study

[*]Prevalence and Risks for Posterior Subcapsular Cataracts in Volunteer Granulocytapheresis Donors

[*]Pilot Study on the Effect of Vitamin A Supplementation on Cone Function in Retinitis Pigmentosa

[*]Treatment of Active Anterior Uveitis Associated with JIA, Using Humanized Anti-Tac (HAT, Daclizumab)

[*]Evaluation of Infliximab in the Treatment of Non-Infectious Scleritis

[*]X-Linked Juvenile Retinoschisis - Clinical and Mocular Studies

[*]A Case Control Study of Age-Related Macular Degeneration (AMD) Examining Gene Expression Patterns in Circulating Monocytes from Peripheral Blood Samples

[*]Analysis of Differential Gene Expression Profiles in Patients with Defined Ocular Inflammatory Diseases Using CDNA Microarrays and Proteomics

[*]Evaluation of Immune Responses to Different Antigens in Non Infectious Ocular Inflammatory Diseases

[*]Clinical and Molecular Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases

[*]Family Studies of Uveal Coloboma

[*]Clinical and Molecular Studiies in Familes with Congenital or Hereditary Cataracts

[*]Pilot Study on the Use of the NASA-NEI Dynamic Light Scattering (DLS) Device in Detecting lens Changes in the other Eye of Patients with Pre-Senile Cataracts

[*]A Phase I/II Randomized, Controlled Study of OGT 918 in Adult and Juvenile Patients with Niemann Pick C Disease

[*]Evaluation and Treatment of Pediatric, Developmental and Genetic Eye Disease

[*]Investigation of the Dietary Docosahexaenoic Acid (DHA) Supplementation on Macular Function in Subjects with Autosomal Dominant Stargardt-Like and Autosomal Recessive Stargardt Macular Dystrophy

[*]Evaluation and Treatment of Ocular Complications of Vaccinia Vaccination: Suitability of NP-016 Vaccinia Immune Globulin (VIG) for Sight-Threatening Conditions [VIG31]

[*]A Multi-Center, Phase I Clinical Trial to Study the Safety of a Sustained-Release Subconjunctival Cyclosporine Implant for Ocular Graft-vs-Host Disease

[*]Combination Daclizumab/Denileukin Diftitox (Ontak) Therapy for the Induction of Immune Tolerance in Non-infectious Intermediate and Posterior Uveitis

[*]Multi-Center, Randomized, Phase II/III Clinical Trial to Study the Effects of Preservative-Free Triamcinolone Acetonide as an Adjunct to Photodynamic Therapy in Participants with Neovascular Age-Related Macular Degeneration

[*]Evaluation of Single Nucleotide Polymorphism (SNP) in Patients with and Subjects without Age-Related Macular Degeneration (AMD)

Last updated: September 15, 2006 at 4:30:37 PM


Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA